Immunology and Microbiology
Cancer Cell
100%
Cycline
100%
Transient Transfection
50%
Immune Complex
50%
Cell Cycle
50%
Proteasome
50%
Cell Cycle M Phase
50%
Pharmacology, Toxicology and Pharmaceutical Science
Bortezomib
100%
Prostate Cancer
100%
Docetaxel
100%
Phosphotransferase
20%
Clinical Trial
10%
Small Interfering RNA
10%
Androgen
10%
Cyclin Dependent Kinase Inhibitor
10%
Taxane
10%
Proteasome
10%
Cyclin Dependent Kinase 1
10%
Neuroscience
Docetaxel
100%
Bortezomib
100%
Kinase
22%
Cell Cycle
11%
Androgen
11%
Small Interfering RNA
11%
Cell Cycle M Phase
11%
Transient Transfection
11%
Cyclin-Dependent Kinase
11%
Proteasome
11%
Taxane
11%
Antigen Antibody Complex
11%
Cyclin Dependent Kinase 1
11%
Keyphrases
Boronate Inhibitors
11%
CDK1 Inhibition
11%